
Patient goals, disease features, and response to prior therapy guide treatment choices across high-risk NMIBC, according to Suzanne B. Merrill, MD, FACS.
In this interview, Jeffrey Weiss, MD, also describes “most exciting area in nocturia research.”
In the third and final installment of Urology Times® Editorial Consultant Gopal Badlani, MD's recent interview with Jeffrey Weiss, MD, Weiss also describes “most exciting area in nocturia research.”






